pharma news today obesity drugs glp-1 today 💊 Millions More Americans Gain Affordable Access to Weight-Loss Through Medicare Starting today, millions of eligible Medicare beneficiaries can access leading medications for as little as $50 per month under GLP-1 Drug Market: the rapid

this is consistent with the fact that previous large clinical trials have not reached a conclusion on whether cardiovascular disease can be suppressed by strict glycaemic control [6]

Lancet (1999) 353(9167):18659

Structure-Activity Relationships and Medicinal Chemistry The optimization of orforglipron from the initial hit compound to a clinical candidate exemplifies modern medicinal chemistry approaches applied to a novel target class

The manufacturers of GLP1-RAs typically recommend lowering doses of insulin and insulin secretagogues at the initiation of GLP-1 RA treatment to reduce the risk of hypoglycemia

doi: 10.2337/db15-0893

Sargeant, J